Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 10, 2009 - Issue 4-3
Submit an article Journal homepage
293
Views
13
CrossRef citations to date
0
Altmetric
Original Investigations

Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: A 12-week open-label, multicentre clinical trial

Henrik Lublin Psychiatric University Center Glostrup, University of Copenhagen, Glostrup, DenmarkCorrespondence[email protected]
,
Hans-joachim Haug Psychological Department, Division of Psychopathology, University of Zurich, Zurich, Switzerland
,
Hannu Koponen Department of Psychiatry, University of Kuopio, Kuopio, Finland
,
Thordur Sigmundsson Division of Psychiatry, Landspitali University Hospital, Reykjavik, Iceland
&
Stefan A. Kolb Pfizer GmbH, Karlsruhe, Germany
Pages 710-718 | Received 02 Nov 2007, Published online: 08 Dec 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Hai Bo Haber Xue, Li Liu, Hena Zhang, William Montgomery & Tamás Treuer. (2014) Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review. Neuropsychiatric Disease and Treatment 10, pages 841-864.
Read now
Hoda Moteshafi & Emmanuel Stip. (2012) Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis. Expert Opinion on Drug Safety 11:5, pages 713-732.
Read now
Alessandro Rossi, Fernando Cañas, Andrea Fagiolini, Ilkka Larmo, Pedro Levy, José Manuel Montes, Georgios Papageorgiou, Runa Sturlason, Mathias Zink & Christoph U. Correll. (2011) Switching among Antipsychotics in Everyday Clinical Practice: Focus on Ziprasidone. Postgraduate Medicine 123:1, pages 135-159.
Read now

Articles from other publishers (10)

Gregory Kruse, Bruce J. O. Wong, Mei Sheng Duh, Patrick Lefebvre, Marie-Hélène Lafeuille & John M. Fastenau. (2015) Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment. PharmacoEconomics 33:10, pages 1049-1067.
Crossref
Young-Hoon KoKyoung-Sae NaChul-Eung KimSeung-Hyun KimYang-Whan JeonJung-Seo YiMoon-Soo LeeShin-Gyeom KimHyun-Ghang JeongHan-Yong Jung. (2014) The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder. Psychiatry Investigation 11:4, pages 459.
Crossref
Miguel Gutiérrez Fraile, Jesús J. de la Gándara Martín & Julio Bobes García. (2013) Switching to Ziprasidone in the Clinical Practice Setting: An Open-Label Study. The International Journal of Psychiatry in Medicine 45:2, pages 125-142.
Crossref
Jian-Jun Ou, Yi Xu, Hong-Hui Chen, Xiaoduo Fan, Keming Gao, Juan Wang, Xiao-Feng Guo, Ren-Rong Wu & Jing-Ping Zhao. (2012) Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia. Psychopharmacology 225:3, pages 627-635.
Crossref
J. Lindenmayer, Frank Tedeschi, Anna Yusim, Anzalee Khan, Saurabh Kaushik, Robert Smith & Mohan Parakadavil. (2012) Ziprasidone's Effect on Metabolic Markers in Patients with Diabetes and Chronic Schizophrenia. Clinical Schizophrenia & Related Psychoses 5:4, pages 185-192.
Crossref
F. Markus Leweke, Thorsten M. Odorfer & J. Malte Bumb. 2012. Current Antipsychotics. Current Antipsychotics 165 185 .
Emmanuel Stip, Simon Zhornitsky, Hoda Moteshafi, Geneviève Létourneau, Irena Stikarovska, Stéphane Potvin & Valérie Tourjman. (2011) Ziprasidone for Psychotic Disorders: A Meta-Analysis and Systematic Review of the Relationship Between Pharmacokinetics, Pharmacodynamics, and Clinical Profile. Clinical Therapeutics 33:12, pages 1853-1867.
Crossref
Thomas L. Schwartz, Stephen M. Stahl, Elizabeth Pappadopulos & Onur N. Karayal. 2011. Bipolar Psychopharmacotherapy. Bipolar Psychopharmacotherapy 223 244 .
Chiara MatteiMaria Paola RapagnaniStephen M. Stahl. (2011) Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?. Journal of Central Nervous System Disease 3, pages JCNSD.S4138.
Crossref
Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Sandra Schwarz, Paranthaman Sethupathi Bhoopathi, Werner Kissling & Stefan Leucht. (2009) Ziprasidone versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.